Literature DB >> 22516427

Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.

Carole L White1, Jeff M Szychowski, Ana Roldan, Marie-France Benavente, Edwin J Pretell, Oscar H Del Brutto, Carlos S Kase, Antonio Arauz, Brett C Meyer, Irene Meissner, Bart M Demaerschalk, Leslie A McClure, Christopher S Coffey, Lesly A Pearce, Robin Conwit, Lisa H Irby, Kalyani Peri, Pablo E Pergola, Robert G Hart, Oscar R Benavente.   

Abstract

This study examined the baseline characteristics, racial/ethnic differences, and geographic differences among participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) study. The SPS3 trial enrolled patients who experienced a symptomatic small subcortical stroke (lacunar stroke) within the previous 6 months and an eligible lesion on detected on magnetic resonance imaging. The patients were randomized, in a factorial design, to antiplatelet therapy (aspirin 325 mg daily plus clopidogrel 75 mg daily vs aspirin 325 mg daily plus placebo) and to one of two levels of systolic blood pressure targets ("intensive" [<130 mmHg] or "usual" [130-149 mmHg]). A total of 3020 participants were recruited from 81 clinical sites in 8 countries. In this cohort, the mean age was 63 years, 63% were men, 75% had a history of hypertension, and 37% had diabetes. The racial distribution was 51% white, 30% Hispanic, and 16% black. Compared with white subjects, black subjects were younger (mean age, 58 years vs 64 years; P <.001) and had a higher prevalence of hypertension (87% vs 70%; P <.001). The prevalence of diabetes was higher in the Hispanic and black subjects compared with the white subjects (42% and 40% vs 32%; both P <.001). Tobacco smoking at the time of qualifying stroke was much more frequent in the Spanish participants than in subjects from North America and from Latin America (32%, 22%, and 9%, respectively; P <.001). Mean systolic blood pressure at study entry was 4 mmHg lower in the Spanish subjects compared with the North American subjects (P <.01). The SPS3 cohort is the largest magnetic resonance imaging-defined series of patients with S3. Among the racially/ethnically diverse SPS3 participants, important differences in patient features and vascular risk factors could influence prognosis for recurrent stroke and response to interventions.
Copyright © 2013 National Stroke Association. All rights reserved.

Entities:  

Keywords:  Lacunar; antiplatelet; blood pressure; clinical trial; cognition; prevention; small vessel disease

Mesh:

Substances:

Year:  2012        PMID: 22516427      PMCID: PMC3970545          DOI: 10.1016/j.jstrokecerebrovasdis.2012.03.002

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  41 in total

1.  Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Salvador Cruz-Flores; Alejandro Rabinstein; Jose Biller; Mitchell S V Elkind; Patrick Griffith; Philip B Gorelick; George Howard; Enrique C Leira; Lewis B Morgenstern; Bruce Ovbiagele; Eric Peterson; Wayne Rosamond; Brian Trimble; Amy L Valderrama
Journal:  Stroke       Date:  2011-05-26       Impact factor: 7.914

2.  Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study.

Authors:  P L Kolominsky-Rabas; M Weber; O Gefeller; B Neundoerfer; P U Heuschmann
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

3.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Authors:  Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

4.  Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups.

Authors:  C Hajat; R Dundas; J A Stewart; E Lawrence; A G Rudd; R Howard; C D Wolfe
Journal:  Stroke       Date:  2001-01       Impact factor: 7.914

5.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

Review 6.  Long-term prognosis after lacunar infarction.

Authors:  Bo Norrving
Journal:  Lancet Neurol       Date:  2003-04       Impact factor: 44.182

Review 7.  Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.

Authors:  Parveen Rashid; Jo Leonardi-Bee; Philip Bath
Journal:  Stroke       Date:  2003-10-23       Impact factor: 7.914

8.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

Authors:  Christophe Tzourio; Craig Anderson; Neil Chapman; Mark Woodward; Bruce Neal; Stephen MacMahon; John Chalmers
Journal:  Arch Intern Med       Date:  2003-05-12

9.  Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project.

Authors:  Lewis B Morgenstern; Melinda A Smith; Lynda D Lisabeth; Jan M H Risser; Ken Uchino; Nelda Garcia; Paxton J Longwell; David A McFarling; Olubumi Akuwumi; Areej Al-Wabil; Fahmi Al-Senani; Devin L Brown; Lemuel A Moyé
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

10.  Long-term prognosis, by stroke subtypes, after a first-ever stroke: a hospital-based study over a 20-year period.

Authors:  Chiaki Yokota; Kazuo Minematsu; Yasuhiro Hasegawa; Takenori Yamaguchi
Journal:  Cerebrovasc Dis       Date:  2004-06-22       Impact factor: 2.762

View more
  22 in total

1.  Predictors of mortality in patients with lacunar stroke in the secondary prevention of small subcortical strokes trial.

Authors:  Mukul Sharma; Lesly A Pearce; Oscar R Benavente; David C Anderson; Stuart J Connolly; Santiago Palacio; Christopher S Coffey; Robert G Hart
Journal:  Stroke       Date:  2014-08-26       Impact factor: 7.914

2.  Long-term disability after lacunar stroke: secondary prevention of small subcortical strokes.

Authors:  Mandip S Dhamoon; Leslie A McClure; Carole L White; Kamakshi Lakshminarayan; Oscar R Benavente; Mitchell S V Elkind
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

3.  Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial.

Authors:  Thalia S Field; Lesly A Pearce; Richard W Asinger; Nathan G Chan Smyth; Sabe K De; Robert G Hart; Oscar R Benavente
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-04-01       Impact factor: 2.136

4.  Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.

Authors:  Lesly A Pearce; Leslie A McClure; David C Anderson; Claudia Jacova; Mukul Sharma; Robert G Hart; Oscar R Benavente
Journal:  Lancet Neurol       Date:  2014-10-23       Impact factor: 44.182

5.  Vertebrobasilar ectasia in patients with lacunar stroke: the secondary prevention of small subcortical strokes trial.

Authors:  Makoto Nakajima; Lesly A Pearce; Nobuyuki Ohara; Thalia S Field; Carlos Bazan; David C Anderson; Robert G Hart; Oscar R Benavente
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-03-25       Impact factor: 2.136

6.  Cognitive performance following lacunar stroke in Spanish-speaking patients: results from the SPS3 trial.

Authors:  Claudia Jacova; Lesly A Pearce; Ana M Roldan; Antonio Arauz; Jorge Tapia; Raymond Costello; Leslie A McClure; Robert G Hart; Oscar R Benavente
Journal:  Int J Stroke       Date:  2015-06       Impact factor: 5.266

7.  Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial.

Authors:  Robert G Hart; Lesly A Pearce; Majid F Bakheet; Oscar R Benavente; Robin A Conwit; Leslie A McClure; Robert L Talbert; David C Anderson
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-06-22       Impact factor: 2.136

8.  Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes.

Authors:  Shuhan Zhu; Leslie A McClure; Helena Lau; Jose R Romero; Carole L White; Viken Babikian; Thanh Nguyen; Oscar R Benavente; Carlos S Kase; Aleksandra Pikula
Journal:  Neurology       Date:  2015-09-15       Impact factor: 9.910

9.  Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience.

Authors:  Carole L White; Jeff M Szychowski; Pablo E Pergola; Thalia S Field; Robert Talbert; Helena Lau; Kalyani Peri; Oscar R Benavente
Journal:  J Am Geriatr Soc       Date:  2015-04-06       Impact factor: 5.562

10.  Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: challenges and lessons learned.

Authors:  Pablo E Pergola; Carole L White; Jeff M Szychowski; Robert Talbert; Oscar Del Brutto; Mar Castellanos; John W Graves; Gonzalo Matamala; Edwin Javier Pretell; Jerry Yee; Rosario Rebello; Yu Zhang; Oscar R Benavente
Journal:  Am J Hypertens       Date:  2014-03-07       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.